The Tinnitus drugs in development market research report provides comprehensive information on the therapeutics under development for Tinnitus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Tinnitus. Buy the report here.

The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Tinnitus and features dormant and discontinued products.

GlobalData tracks eight drugs in development for Tinnitus by seven companies/universities/institutes. The top development phase for Tinnitus is preclinical with five drugs in that stage. The Tinnitus pipeline has six drugs in development by companies and two by universities/ institutes. Some of the companies in the Tinnitus pipeline products market are: Gateway Biotechnology, Safety Shot and University of Pittsburgh School of Medicine.

The key targets in the Tinnitus pipeline products market include Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3), Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2), and Neurotrophic Factor .

The key mechanisms of action in the Tinnitus pipeline product include Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) Activator with two drugs in Preclinical. The Tinnitus pipeline products include four routes of administration with the top ROA being Oral and one key molecule types in the Tinnitus pipeline products market including Small Molecule.

Tinnitus overview

Tinnitus is a condition characterized by ringing, swishing, or other noises that originating in the ear or head. Causes of tinnitus are age-related hearing loss, exposure to loud noises, earwax blockage in the ear canal, smoking, and abnormal bone growth in the ear. Symptoms include ringing, buzzing, roaring, clicking, whistling, hissing, or squealing noises, which may be low or high in pitch.

For a complete picture of Tinnitus’s pipeline drug market, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.